CHAOJU EYE CARE (02219) announced that on April 1, 2026, its indirectly wholly-owned subsidiary, Chaoju Medical Technology, purchased financial products from BANK OF CHINA with a total principal amount of RMB 260 million.
CHAOJU EYE CARE (02219) announced that on April 1, 2026, its indirectly wholly-owned subsidiary, Chaoju Medical Technology, purchased financial products from BANK OF CHINA with a total principal amount of RMB 260 million.
Comments